Product Profiles

Article

Product profiles

Sterilization containers

Microstop features new filter technology that was developed in conjunction with German research organization the Fraunhofer Institute. Constructed from aluminium, the Microstop includes a filter disc that acts as a sterility barrier. The filter disc separates air current and microorganisms, meaning it is less time-consuming. The instruments can be cleaned in one sieve, thus reducing loading and uploading times for operating room staff.

For further details please visit http://www.geuder.de/ or contact info@geuder.de

Viscosurgical formula

The Healon EndoCoat OVD features a smaller, 25-gauge cannula with guard and improved ergonomics. This provides smooth and consistent delivery as well as safety and comfort for both the patient and surgeon.

The formula protects and coats the eye when injected during surgery, and is ideal for intraocular lens (IOL) lubrication and insertion. All Healon products can be used in conjunction with Healon EndoCoat OVD. This includes Healon OVD, Healon GV OVD or Healon5 OVD.

For further details please visit http://www.abbott.com/

Preservative-free drops

The eye drops are an ideal solution for patients who experience side effects from glaucoma eye drops with preservatives. Taflotan is also well-suited for dry and sensitive eyes.

Results from several recent studies have demonstrated the safety and efficacy of Taflotan. The eye drops reduce ocular symptoms and signs.

Learn more about this and Santen's other offerings at http://www.santen.eu/

Planar corneal lamellar grafts

The system also consists of a single-use artificial chamber, special inflation tubing and syringe sets, and a turbine-driven Moria CB Microkeratome with control unit. The artificial chamber and the rotating guide ring allow for two cuts in the opposite quadrants of the cornea, meaning grafts are much more planar.

Pressure is constantly maintained in the system due to the presence of inflation tubing and the infusion syringe. The handling and insertion of the ultra-thin grafts is enabled by the Mini Busin Spatula and Forceps.

For further information please contact prollier@moria-int.com

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.